tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ALNY Stock Latest News

Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
The FlyAlnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
1h ago
SNY
ALNY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1d ago
ALLR
ALNY
Investors should buy Codexis following contract news, says Craig-Hallum
PremiumThe Fly
Investors should buy Codexis following contract news, says Craig-Hallum
3d ago
DHR
ALNY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3d ago
IBO
ADPT
Cantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burden
PremiumThe Fly
Cantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burden
3d ago
SNY
ALNY
Alnylam upgraded to Overweight from Neutral at JPMorgan
PremiumThe FlyAlnylam upgraded to Overweight from Neutral at JPMorgan
5d ago
ALNY
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
Premium
Market News
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
7d ago
ALNY
Alnylam Pharma’s Promising Future: Buy Rating Backed by AMVUTTRA’s FDA Approval and Market Leadership Potential
Premium
Ratings
Alnylam Pharma’s Promising Future: Buy Rating Backed by AMVUTTRA’s FDA Approval and Market Leadership Potential
7d ago
ALNY
Alnylam price target raised to $338 from $300 at Scotiabank
PremiumThe Fly
Alnylam price target raised to $338 from $300 at Scotiabank
7d ago
ALNY
Alnylam price target raised to $330 from $310 at RBC Capital
PremiumThe Fly
Alnylam price target raised to $330 from $310 at RBC Capital
7d ago
ALNY
Alnylam Pharma’s Strategic Advancements and Market Potential Support Buy Rating
PremiumRatings
Alnylam Pharma’s Strategic Advancements and Market Potential Support Buy Rating
7d ago
ALNY
Alnylam Pharma’s Amvuttra Gains FDA Approval, Positioned as Leading siRNA Treatment for ATTR-CM
PremiumRatings
Alnylam Pharma’s Amvuttra Gains FDA Approval, Positioned as Leading siRNA Treatment for ATTR-CM
7d ago
ALNY
Alnylam price target raised to $325 from $302 at BofA
PremiumThe FlyAlnylam price target raised to $325 from $302 at BofA
7d ago
ALNY
Alnylam price target raised to $390 from $385 at Canaccord
Premium
The Fly
Alnylam price target raised to $390 from $385 at Canaccord
7d ago
ALNY
Positive Outlook for Alnylam Pharma Following FDA Approval of Amvuttra for TTR-CM
Premium
Ratings
Positive Outlook for Alnylam Pharma Following FDA Approval of Amvuttra for TTR-CM
7d ago
ALNY
Alnylam price target raised to $351 from $338 at Citi
PremiumThe Fly
Alnylam price target raised to $351 from $338 at Citi
7d ago
ALNY
Alnylam Pharma’s Strategic Positioning and Market Potential Boosted by Early FDA Approval of Amvuttra
PremiumRatings
Alnylam Pharma’s Strategic Positioning and Market Potential Boosted by Early FDA Approval of Amvuttra
7d ago
ALNY
Alnylam price target raised to $287 from $275 at Wells Fargo
PremiumThe Fly
Alnylam price target raised to $287 from $275 at Wells Fargo
7d ago
ALNY
Cautious Outlook on Alnylam Pharma Amid Amvuttra’s FDA Approval and Pricing Concerns
PremiumRatings
Cautious Outlook on Alnylam Pharma Amid Amvuttra’s FDA Approval and Pricing Concerns
8d ago
ALNY
Buy Recommendation for Amvuttra: Strong Clinical Data and Strategic Market Positioning Drive Growth Potential
PremiumRatingsBuy Recommendation for Amvuttra: Strong Clinical Data and Strategic Market Positioning Drive Growth Potential
8d ago
ALNY
Alnylam’s Amvuttra approved by FDA in cardiomyopathy
Premium
The Fly
Alnylam’s Amvuttra approved by FDA in cardiomyopathy
8d ago
ALNY
Alnylam trading halted, news pending
Premium
The Fly
Alnylam trading halted, news pending
8d ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >